Grant: Master's Award: Canada Graduate Scholarships
University of British Columbia
$17,500.00
Gene expression regulation in recurrent paediatric acute myeloid leukaemia by characterization of non-coding ribonucleic acids
FY 2020-21
Summary
Despite research advances leading to better treatments, paediatric cancers continue to claim the lives of children year after year. Cancer recurrence or relapse occurs after treatment initially appears to be successful, but later the cancer returns. In the case of paediatric acute myeloid leukaemia (AML), children who relapse are known to have poorer clinical outcomes than those that stay in remission. Like other cancers, paediatric AML is partly caused by mutations in genes in certain human cells. In addition, how these genes are regulated and how they become dysregulated in cancer, is partially due to the activity of certain ribonucleic acids (RNAs), collectively called non-coding RNAs (ncRNAs). There are many kinds of ncRNAs and a number have been found to have varied roles in maintaining cells in non-cancerous states. Logically, when certain ncRNAs do not function in the way they are supposed to, cancer may develop. Hence, by characterizing ncRNAs in paediatric AML, a better understanding of why some children relapse and others do not, may emerge. Most importantly, it is hoped that this understanding may facilitate the development of better treatments that improve the outcomes for kids with paediatric AML.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
449784
Name
MacLennan Signe A
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Gene expression regulation in recurrent paediatric acute myeloid leukaemia by characterization of non-coding ribonucleic acids
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Bioinformatics; Cancer Genetics; Cancer Recurrence; Cellular Heterogeneity; Gene Expression Analysis; Gene Regulation; Non-Coding Rnas; Paediatric Acute Myeloid Leukaemia; Paediatric Cancer; Single-Cell Rna Sequencing
Abstract
Despite research advances leading to better treatments, paediatric cancers continue to claim the lives of children year after year. Cancer recurrence or relapse occurs after treatment initially appears to be successful, but later the cancer returns. In the case of paediatric acute myeloid leukaemia (AML), children who relapse are known to have poorer clinical outcomes than those that stay in remission. Like other cancers, paediatric AML is partly caused by mutations in genes in certain human cells. In addition, how these genes are regulated and how they become dysregulated in cancer, is partially due to the activity of certain ribonucleic acids (RNAs), collectively called non-coding RNAs (ncRNAs). There are many kinds of ncRNAs and a number have been found to have varied roles in maintaining cells in non-cancerous states. Logically, when certain ncRNAs do not function in the way they are supposed to, cancer may develop. Hence, by characterizing ncRNAs in paediatric AML, a better understanding of why some children relapse and others do not, may emerge. Most importantly, it is hoped that this understanding may facilitate the development of better treatments that improve the outcomes for kids with paediatric AML.
Competitiondate
202012
Approvedterm2
1 yr 0 mth
Pinamesdelim
MacLennan, Signe A
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~